1 |
Li MO, Wan YY, Sanjabi S, Robertson AK, Flavell RA. Transforming growth factor-beta regulation of immune responses. Annu Rev Immunol. 2006;24:99-146.
DOI
|
2 |
Letterio JJ, Roberts AB. Regulation of immune responses by TGF- . Annu Rev Immunol. 1998;16:137-161.
DOI
|
3 |
Wahl SM. Transforming growth factor : the good, the bad, and the ugly. J Exp Med. 1994;180:1587-1590.
DOI
|
4 |
Kehrl JH, Wakefield LM, Roberts AB, Jakowlew S, Alvarez-Mon M, Derynck R, et al. Production of transforming growth factor by human T lymphocytes and its potential role in the regulation of T cell growth. J Exp Med. 1986;163:1037-1050.
DOI
|
5 |
Chen Y, Kuchroo VK, Inobe J, Hafler DA, Weiner HL. Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science. 1994;265:1237-1240.
DOI
|
6 |
Weiner HL. Induction and mechanism of action of transforming growth factor- -secreting Th3 regulatory cells. Immunol Rev. 2001;182:207-214.
DOI
|
7 |
Nakamura K, Kitani A, Strober W. Cell contact-dependent immunosuppression by CD4+CD25+ regulatory T cells is mediated by cell surface-bound transforming growth factor . J Exp Med. 2001;194:629-644.
DOI
|
8 |
Oida T, Zhang X, Goto M, Hachimura S, Totsuka M, Kaminogawa S, et al. CD4+CD25- Tcells that express latencyassociated peptide on the surface suppress CD4+CD45RBhighinduced colitis by a TGF- -dependent mechanism. J Immunol. 2003;170:2516-2522.
DOI
|
9 |
Green EA, Gorelik L, McGregor CM, Tran EH, Flavell RA. CD4+CD25+ T regulatory cells control anti-islet CD8+ T cells through TGF- receptor interactions in type 1 diabetes. Proc Natl Acad Sci. 2003;100:10878-10883.
DOI
|
10 |
Piccirillo CA, Letterio JJ, Thornton AM, McHugh RS, Mamura M, Mizuhara H, et al. CD4+CD25+ regulatory T cells can mediate suppressor function in the absence of transforming growth factor 1 production and responsiveness. J Exp Med. 2002; 196:237-246.
DOI
|
11 |
Nakamura K, Kitani A, Fuss I, Pedersen A, Harada N, Nawata H, et al. TGF- 1 plays an important role in the mechanism of CD4+CD25+ regulatory T cell activity in both humans and mice. J Immunol. 2004;172:834-842.
DOI
|
12 |
Powrie F, Carlino J, Leach MW, Mauze S, Coffman RL. A critical role for transforming growth factor- but not interleukin 4 in the suppression of T helper type 1-mediated colitis by CD45RB(low) CD4+ T cells. J Exp Med. 1996;183:2669-2674.
DOI
|
13 |
Mamura M, Lee W, Sullivan TJ, Felici A, Sowers AL, Allison JP, Letterio JJ. CD28 disruption exacerbates inflammation in TGF- 1-/- mice: in vivo suppression by CD4+CD25+ regulatory T cells independent of autocrine TGF- 1. Blood. 2004; 103:4594-601.
DOI
|
14 |
Fahlen L, Read S, Gorelik L, Hurst SD, Coffman RL, Flavell RA, et al. T cells that cannot respond to TGF- escape control by CD4+CD25+regulatory T cells. J Exp Med. 2005;201:737-746.
DOI
|
15 |
Namba K, Kitaichi N, Nishida T, Taylor AW. Induction of regulatory T cells by the immunomodulating cytokines alpha-melanocyte-stimulating hormone and transforming growth factor-beta2. J Leukoc Biol. 2002;72:946-952.
|
16 |
Fantini MC, Becker C, Monteleone G, Pallone F, Galle PR, Neurath MF. Cutting edge: TGF-beta induces a regulatory phenotype in CD4+CD25- T cells through Foxp3 induction and down-regulation of Smad7. J Immunol. 2004;172:5149-5153.
DOI
|
17 |
Tonkin DR, Haskins K. Regulatory T cells enter the pancreas during suppression of type 1 diabetes and inhibit effector T cells and macrophages in a TGF-beta-dependent manner. Eur J Immunol. 2009;39:1313-1322.
DOI
|
18 |
Calderon B, Suri A, Pan XO, Mills JC, Unanue ER. IFN-gamma-dependent regulatory circuits in immune inflammation highlighted in diabetes. J Immunol. 2008;181:6964-6974.
DOI
|
19 |
Tran DQ, Ramsey H, Shevach EM. Induction of FOXP3 expression in naive human CD4+FOXP3 T cells by T-cell receptor stimulation is transforming growth factor-beta dependent but does not confer a regulatory phenotype. Blood. 2007;110: 2983-2990.
DOI
|
20 |
Lin HM, Lee JH, Yadav H, Kamaraju AK, Liu E, Zhigang D, et al. Transforming growth factor-beta/Smad3 signaling regulates insulin gene transcription and pancreatic islet beta-cell function. J Biol Chem. 2009;284:12246-12257.
DOI
|
21 |
Zang W, Lin M, Kalache S, Zhang N, Kruger B, Waaga-Gasser AM, et al. Inhibition of the alloimmune response through the generation of regulatory T cells by a MHC class II-derived peptide. J Immunol. 2008;181:7499-7506.
DOI
|
22 |
Simeone DM, Zhang L, Treutelaar MK, Zhang L, Graziano K, Logsdon CD, et al. Islet hypertrophy following pancreatic disruption of Smad4 signaling. Am J Physiol Endocrinol Metab. 2006;291:E1305-1316.
DOI
|
23 |
Sabek OM, Fraga DW, Henry J, Gaber LW, Kotb M, Gaber AO, et al. Expression of transforming growth factor by human islets: impact on islet viability and function. Cell Transplantation. 2007;16:775-785.
DOI
|
24 |
Chao KC, Chao KF, Chen CF, Liu SH. A novel human stem cell coculture system that maintains the survival and function of culture islet-like cell clusters. Cell Transplant. 2008;17: 657-664.
DOI
|
25 |
Choi SE, Choi KM, Yoon IH, Shin JY, Kim JS, Park WY, et al. IL-6 protects pancreatic islet beta cells from pro-inflammatory cytokines-induced cell death and functional impairment in vitro and in vivo. Transpl Immunol. 2004;13:43-53.
DOI
|
26 |
Kamimura D, Ishihara K, Hirano T. IL-6 signal transduction and its physiological roles: the signal orchestration model. Rev Physiol Biochem Pharmacol. 2003;149:1-38.
|
27 |
Birkey Reffey S, Wurthner JU, Parks WT. X-linked inhibitor of apoptosis protein functions as a cofactor in transforming growth factor- signaling. J Biol Chem. 2001;276:26542-26549.
DOI
|
28 |
Sayo Y, Hosokawa H, Imachi H, Murao K, Sato M, Wong NC, et al. Transforming growth factor induction of insulin gene expression in mediated by pancreatic and duodenal homeobox gene-1 in rat insulinoma cells. Eur J Biochem. 2000;267: 971-978.
DOI
|